Academic Journal

Efficacy and Safety of Ixekizumab vs. Low-Dose IL-2 vs. Colchicine vs. Standard of Care on the Treatment of Patients Hospitalized with Moderate to Critical Covid-19: A Pilot Randomized Clinical Trial (STRUCK: S urvival T rial U sing C yto k ine Inhibitors)

التفاصيل البيبلوغرافية
العنوان: Efficacy and Safety of Ixekizumab vs. Low-Dose IL-2 vs. Colchicine vs. Standard of Care on the Treatment of Patients Hospitalized with Moderate to Critical Covid-19: A Pilot Randomized Clinical Trial (STRUCK: S urvival T rial U sing C yto k ine Inhibitors)
المؤلفون: Pimenta Bonifácio, Lívia, Ramacciotti, Eduardo, Agati, Leandro Barile, Vilar, Fernando C., Tojal da Silva, Anna Christina, Louzada-Junior, Paulo, Fonseca, Benedito Antonio Lopes da, de Souza, Hayala Cristina Cavenague, de Oliveira, Caroline Candida Carvalho, Aguiar, Valéria Cristina Resende, de Aguiar Quadros, Carlos Augusto, Dusilek, Cesar, Itinose, Kenji, Risson, Ricardo Gustavo Zill, Ferreira, Lucas Roberto Rivabem, Dedivitis, Rogério Aparecido, Cortina, André Sementilli, Lopes, Renato Delascio, Kallas, Esper Georges, Bellissimo-Rodrigues, Fernando
المصدر: SSRN Electronic Journal ; ISSN 1556-5068
بيانات النشر: Elsevier BV
سنة النشر: 2022
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.2139/ssrn.4095747
الاتاحة: http://dx.doi.org/10.2139/ssrn.4095747
رقم الانضمام: edsbas.DFB3AF5C
قاعدة البيانات: BASE